HESTERBIO — Hester Biosciences Share News
0.000.00%
- IN₹17.50bn
- IN₹19.24bn
- IN₹3.33bn
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD
Brief: Hester Biosciences Says Ashish Desai Appointed As Chief Financial Officer
India's Hester Biosciences hits over 1-mth low on Q4 profit fall
Brief: India's Hester Biosciences March-Qtr Consol Net Profit Falls
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & Managing Director
India's Hester Biosciences hits 1-month high on Q3 profit jump
India's Hester Biosciences up on tech deal for avian flu vaccine
Brief: Hester Biosciences Acquires Technology From Icar - Nihsad To Develop A Low Pathogenic Avian Influenza (H9n2 Strain) Inactivated Vaccine
India's Hester Biosciences jumps 13% on demand for cattle vaccine
Brief: India's Hester Biosciences June-Quarter Consol Net Profit Falls
Brief: Hester Biosciences March-Qtr Consol Net Profit Falls
Brief: Hester Biosciences Approves Execution Of Grantin-Aid Letter Agreement To Co By BIRAC
Brief: Hester Biosciences Says To Expand Into Pet Care Sector
Media: Hester Biosciences to roll out Covaxin drug substance by April 2022- ET
Brief: Hester Biosciences Says To Consider Borrowings Of Additional Funds As Loan
Brief: Hester Biosciences Says Hester India To Buy 50% Stake In Thrishool Exim Ltd